{"title":"Patterns of antibiotics and pathogens for anastomotic leakage after colorectal cancer surgery","authors":"G. Yang, Chang Woo Kim, Suk-Hwan Lee","doi":"10.14216/kjco.19015","DOIUrl":null,"url":null,"abstract":"Intra-abdominal infection (IAI) represents a wide variety of pathological conditions that can involve lesions of all the intra-abdominal organs. It should be treated with appropriate antibiotic therapy with proper interventions for source control. Choice of appropriate antibiotic must be based on the results of the culture study; the strain that caused the infection, profile of bacteria, and resistance to antibiotics. However, because the results usually require a few days, empirical antibiotics should be administered first, and then, the extension of the administration or the replacement of antibiotics can be considered depending on the results of the test [1]. Antibiotic resistance disables several mechanisms of antibiotics against bacteria, subsequently increases medical expense, as well as affects effectiveness of antibiotics against infection [2-4]. The Centers for Disease Control and Prevention has reported that the estimated minimum number of illnesses and deaths caused by antibiotics resistance were at least 2 million illness and 23,000 deaths each year in the United States [5]. In addition, guidelines already recommend appropriate antimicrobial agents on the basis of high-quality evidence and advise understanding of the microbiological profiles and resistance of the key pathogens causing IAI in Original Article Korean Journal of Clinical Oncology 2019;15:79-85 https://doi.org/10.14216/kjco.19015 pISSN 1738-8082 ∙ eISSN 2288-4084","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"185 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Korean journal of clinical oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14216/kjco.19015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
Intra-abdominal infection (IAI) represents a wide variety of pathological conditions that can involve lesions of all the intra-abdominal organs. It should be treated with appropriate antibiotic therapy with proper interventions for source control. Choice of appropriate antibiotic must be based on the results of the culture study; the strain that caused the infection, profile of bacteria, and resistance to antibiotics. However, because the results usually require a few days, empirical antibiotics should be administered first, and then, the extension of the administration or the replacement of antibiotics can be considered depending on the results of the test [1]. Antibiotic resistance disables several mechanisms of antibiotics against bacteria, subsequently increases medical expense, as well as affects effectiveness of antibiotics against infection [2-4]. The Centers for Disease Control and Prevention has reported that the estimated minimum number of illnesses and deaths caused by antibiotics resistance were at least 2 million illness and 23,000 deaths each year in the United States [5]. In addition, guidelines already recommend appropriate antimicrobial agents on the basis of high-quality evidence and advise understanding of the microbiological profiles and resistance of the key pathogens causing IAI in Original Article Korean Journal of Clinical Oncology 2019;15:79-85 https://doi.org/10.14216/kjco.19015 pISSN 1738-8082 ∙ eISSN 2288-4084
腹腔感染(IAI)是一种广泛的病理情况,可涉及腹腔内所有器官的病变。应采用适当的抗生素治疗,并采取适当的干预措施进行源头控制。选择合适的抗生素必须基于培养研究的结果;引起感染的菌株,细菌的特征,以及对抗生素的耐药性。但由于结果通常需要几天时间,因此应先给予经验性抗生素,然后根据试验结果考虑延长给药或更换抗生素。抗生素耐药性使抗生素对抗细菌的几种机制失效,从而增加医疗费用,并影响抗生素抗感染的有效性[2-4]。美国疾病控制与预防中心(Centers for Disease Control and Prevention)报告称,美国每年因抗生素耐药性而导致的患病和死亡人数估计至少为200万,死亡人数为2.3万。此外,指南已经在高质量证据的基础上推荐了适当的抗微生物药物,并建议了解导致IAI的关键病原体的微生物学特征和耐药性(详见《韩国临床肿瘤学杂志》2019;15:79-85 https://doi.org/10.14216/kjco.19015 pISSN 1738-8082∙eISSN 2288-4084)